BAX and hepatocellular carcinoma: The expression of Bax was significantly lower in HCC patients compared to the controls (0.36 ± 0.34 vs. 1.20 ± 0.95, p = 0.001, Figure 1b), while Bcl-2 expression was higher in patients than in controls (4.16 ± 3.44 vs. 1.27 ± 0.98, p = 0.003, Figure 1c).